Fosamax
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
—Fosamax (Alendronate) is an approved drug widely prescribed for osteoporosis treatment and other bone damaging diseases. Fosamax…
A 90-year old woman attended a department of Oral and Maxillofacial Surgery with a tongue that had been painful for at least 3…
The reluctance of physicians to use estrogens in women with hormone responsive disorders is a tragic result of the 2002 WHI study…
A New York judge has revealed internal Merck discussions about a possible link between its widely prescribed drug and dead jaw…
VOLUME 26 NUMBER 4 APRIL 2008 NATURE BIOTECHNOLOGY Most osteoporosis therapies act by inhibiting osteoclast-mediated bone…
Alendronate (Fosamax, Merck Sharp & Dohme) is an aminobisphosphonate which inhibits bone turnover by suppressing the activity of…
L'alendronate de sodium (Fosamax®, Merck Sharp & Dohme) est un aminobisphosphonate dote d'une activite inhibitrice sur l'activite…